Skip to content
healthcare.dev

Chlorzoxazone

NDC 0254-2053, Chlorzoxazone, tablet, from Par Health USA, LLC.

Product NDC
0254-2053
Status
Listed
Labeler
Par Health USA, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212743
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0254-2053 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHLORZOXAZONE375 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
0254-2053-0100254205301100 TABLET in 1 BOTTLE (0254-2053-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7c5a835d-3754-4c25-a0e2-335b8eceb2d2
  • NADAC price for package 00254205301

    GET /v1/drugs/nadac/00254205301

Use it

Look up 0254-2053 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0254-2053 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0254-2053. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.